Researchers from Tampa, Fla.-based Moffitt Cancer Center are investigating whether primary or metastatic tumors can be used to produce personalized neoantigen-targeted cancer vaccines.
The Latest
The American Oncology Network has launched a foundation to provide cancer patients with funding for non-medical related expenses, the organization announced Nov. 3.
Researchers at Boston-based Mass General Brigham have discovered a key mutation that may be a driving factor in resistance to certain drugs used to treat breast cancer patients, according to a Nov. 2 news release.
Researchers at the National Cancer Institute may be inching closer to an improved type of T-cell therapy that could "supercharge" their response against solid tumors, according to a Nov. 1 news release.
The American Cancer Society updated its lung cancer screening guidelines for the first time in a decade, with the goal of reducing deaths from disease due to smoking history.
Access to care, eliminating disparities and expanding quality care are the top three things leaders want changed about cancer care.
The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
Minneapolis-based Allina Health Cancer Institute is launching a first-of-its-kind clinical trial using artificial intelligence and a simple blood draw to find and diagnose cancer.
A study found oncologists who receive industry payments might be more likely to provide non-recommended and low-value treatment to cancer patients.
Safe handling of chemotherapy drugs is challenging but essential for oncology centers